| Literature DB >> 33031049 |
Andreas Älgå1,2, Oskar Eriksson3, Martin Nordberg1.
Abstract
BACKGROUND: The COVID-19 pandemic has spread at an alarming speed, and effective treatment for the disease is still lacking. The body of evidence on COVID-19 has been increasing at an impressive pace, creating the need for a method to rapidly assess the current knowledge and identify key information. Gold standard methods such as systematic reviews and meta-analyses are regarded unsuitable because they have a narrow scope and are very time consuming.Entities:
Keywords: COVID-19; SARS-CoV-2; coronavirus; literature; pandemic; research; topic modeling
Mesh:
Year: 2020 PMID: 33031049 PMCID: PMC7674137 DOI: 10.2196/21559
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Data processing flowchart. Italicized text indicate the method used. JIF: journal impact factor.
Figure 2Number of articles published per week and the corresponding median journal impact factor.
Figure 3Principal component analysis plot for the chosen latent Dirichlet allocation model with 14 topics. Overlaps are seen for three topic clusters; however, these topics were found to be separated by clinical relevance.
COVID-19 topics from latent Dirichlet allocation modeling.
| Topic No. | Label | Five most-frequent terms based on latent Dirichlet allocation | Five most-frequent PubMed keywords | Journal impact factor, median (IQR) | Articles published, n (%) (N=16,670) |
| 1 | Laboratory diagnostics | antibody, time, laboratory, diagnostic, assay | pcr, rt, testing, disease, test | 3.36 (2.0-6.1) | 599 (3.59) |
| 2 | Therapies and vaccines | chloroquine, anti, hydroxychloroquine, pandemic, potential | hydroxychloroquine, chloroquine, drug, disease, antiviral | 4.10 (2.9-6.6) | 1193 (7.15) |
| 3 | Risk factors | ecmo, renin, respiratory, clinical, risk | diabetes, angiotensin, ace, disease, enzyme | 4.13 (2.9-6.5) | 420 (2.51) |
| 4 | Health care response | worker, response, practice, service, recommendation | health, pandemic, public, infection, disease | 3.39 (2.4-5.1) | 2812 (16.86) |
| 5 | Epidemiology | risk, control, datum, period, rate | disease, respiratory, epidemiology, novel, infection | 4.09 (2.8-6.3) | 819 (4.91) |
| 6 | Disease transmission | cause, spread, health, transmission, outbreak | respiratory, disease, syndrome, acute, virus | 3.36 (2.5-6.2) | 1141 (6.84) |
| 7 | Impact on health care practices | change, resident, time, virtual, visit | education, telemedicine, pandemic, health, medical | 3.86 (2.5-5.7) | 1115 (6.68) |
| 8 | Radiology | imaging, tomography, lesion, diagnosis, feature | pneumonia, tomography, computed, disease, ct | 3.69 (2.7-5.5) | 774 (4.64) |
| 9 | Epidemiological modeling | control, spread, measure, public, italy | health, pandemic, model, disease, public | 3.48 (2.5-5.2) | 1219 (7.31) |
| 10 | Clinical manifestations | increase, associate, infection, cardiovascular, injury | disease, acute, syndrome, respiratory, severe | 4.99 (3.3-7.8) | 1828 (10.96) |
| 11 | Protective measures | equipment, high, practice, perform, protective | surgery, cancer, pandemic, management, personal | 4.50 (2.6-5.5) | 1466 (8.79) |
| 12 | Immunology | expression, target, inhibitor, enzyme, viral | ace, angiotensin, protein, molecular, converting | 4.56 (3.1-8.1) | 694 (4.16) |
| 13 | Pregnancy | systematic, datum, include, disease, search | pregnancy, infection, respiratory, transmission, disease | 3.52 (2.3-5.1) | 819 (4.91) |
| 14 | Psychological impact | increase, stress, old, physical, public | health, pandemic, mental, social, anxiety | 3.35 (2.4-5.0) | 1771 (10.62) |
Figure 4Proportion of topics in relation to all COVID-19 articles published per week.
Figure 5Geographic origins of the 16,670 published COVID-19 articles analyzed. Lat: latitude, Long: longitude.